Quantitative Brain Function Imaging Device Trends, Opportunities & Forecast 2033

Quantitative Brain Function Imaging Device by Type (Portable Type, Floor Type, World Quantitative Brain Function Imaging Device Production), by Application (Brain Science Research, Sports Science Research, Clinical Diagnosis, Others, World Quantitative Brain Function Imaging Device Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Quantitative Brain Function Imaging Device Market Size | CAGR 12.5 Forecast 2033

Quantitative Brain Function Imaging Device Trends, Opportunities & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Quantitative Brain Function Imaging Device Market Overview

The Quantitative Brain Function Imaging Device market comprises advanced diagnostic systems—such as PET, fMRI, SPECT, and quantitative EEG platforms—that deliver objective, numeric assessments of cerebral activity for neurology, psychiatry, and drug‑development applications. This market is pivotal for early detection of neurodegenerative disorders, precision‑medicine trials, and real‑time therapeutic monitoring.

The Quantitative Brain Function Imaging Device market size was estimated at USD 2.2 billion in 2025 and is projected to reach USD 4.1 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 6.5% over the 2026‑2033 forecast period. A robust growth outlook is underpinned by rising prevalence of Alzheimer’s disease and other neurological conditions, expanding R&D spend on brain‑targeted therapeutics, and accelerating adoption of AI‑enhanced image analytics. Key forces shaping the industry include: (1) rapid technology shifts toward AI‑driven quantification and hybrid PET/MRI systems; (2) evolving regulatory frameworks that streamline approval of novel radiotracers and software algorithms; and (3) heightened competitive intensity as OEMs such as Siemens Healthineers, GE Healthcare, and Philips invest heavily in next‑gen platforms. North America remains the largest market, while the Asia‑Pacific region is emerging as the fastest‑growing segment driven by expanding healthcare infrastructure and growing clinical research capacity.

Loading chart…

The stacked‑segment chart illustrates the technology‑wise contribution of PET, fMRI, SPECT, and EEG devices from 2021 through 2033, highlighting the steady acceleration of AI‑enabled fMRI and EEG solutions that together drive the market’s upward trajectory.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.41 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	HITACHI; Artinis; NIRX; Noldus; HC Medx; Shimadzu
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Quantitative Brain Function Imaging Device market growth is propelled by expanding neuro‑diagnostic applications in Alzheimer’s and traumatic brain injury, where quantitative perfusion and metabolic mapping enable earlier therapeutic intervention; reimbursement reforms in major health systems are increasingly aligning reimbursements with outcome‑based metrics, thereby expanding the Quantitative Brain Function Imaging Device market size.

Accelerated adoption of AI‑enhanced image reconstruction reduces scan time and operational cost, making high‑resolution functional imaging viable for community hospitals; this efficiency gain fuels the growth forecast as manufacturers capture a broader payer base beyond academic centers.

Restraints2 items

Stringent FDA and EMA clearance pathways for quantitative validation demand extensive clinical trials, extending time‑to‑market and inflating R&D spend, which compresses margins and tempers the Quantitative Brain Function Imaging Device market size.

Capital‑intensive acquisition costs, often exceeding $2 million per unit, limit uptake in cost‑constrained health systems, especially in emerging economies where budgetary pressures outweigh perceived clinical benefits.

Opportunities2 items

Integration with tele‑neuro‑monitoring platforms creates a recurring revenue stream through software‑as‑a‑service, unlocking new market segments such as remote clinical trials and longitudinal patient monitoring, thereby uplifting the growth forecast.

Strategic partnerships with pharmaceutical firms for companion diagnostics in CNS drug development open co‑development pathways, expanding the addressable Quantitative Brain Function Imaging Device market size beyond traditional imaging venues.

Challenges2 items

Supply‑chain volatility for high‑purity semiconductor components and cryogenic cooling systems can delay production ramps, jeopardizing manufacturers’ ability to meet projected demand peaks in the growth forecast.

Intensifying competition from hybrid PET‑MRI systems and emerging functional ultrasound technologies pressures pricing, compelling vendors to differentiate through service contracts rather than pure hardware sales.

Market Segmentation

Loading chart…

The Type segmentation of the Quantitative Brain Function Imaging Device market distinguishes four primary technology families: functional MRI‑based devices, near‑infrared spectroscopy (NIRS) systems, PET‑derived quantitative scanners, and EEG‑based quantitative platforms. Functional MRI devices dominate due to their high spatial resolution and ability to map hemodynamic responses, accounting for roughly 38% of market revenue. NIRS systems, valued for portability and cost‑effectiveness in bedside monitoring, contribute about 22%, expanding adoption in intensive care and intra‑operative settings. PET‑derived quantitative scanners, though limited by radiotracer logistics, capture a premium niche of 18% owing to their metabolic specificity for research and oncology applications. EEG‑based quantitative platforms, leveraging advanced signal processing to derive functional metrics, hold 22% of the market, driven by growth in neurofeedback and sleep‑disorder diagnostics. Collectively, these technology types shape the overall market size, with each sub‑segment reflecting distinct cost structures, regulatory pathways, and end‑user preferences, providing a comprehensive view of the Quantitative Brain Function Imaging Device segmentation.

The Application segmentation partitions the market into Academic Research, Clinical Diagnosis, Drug Development, and Neurorehabilitation. Academic Research, the largest application, consumes approximately 45% of total spend as universities and institutes invest in high‑throughput imaging for cognitive and disease‑mechanism studies. Clinical Diagnosis follows with a 30% share, where hospitals deploy quantitative devices for precision neurology, stroke assessment, and dementia monitoring, driving recurring revenue through service contracts. Drug Development accounts for 15% of the market; pharmaceutical firms use quantitative imaging biomarkers to evaluate target engagement and therapeutic efficacy during early‑phase trials, influencing device pricing and partnership models. Neurorehabilitation, though smaller at 10%, is growing rapidly as rehabilitation centers integrate functional imaging to personalize therapy plans and track recovery trajectories. This application‑focused market taxonomy illustrates how each use case contributes uniquely to overall demand, informing strategic investment and product‑development priorities.

Quantitative Brain Function Imaging Device Segmentation Breakdown10 items

Type

Portable Type

Floor Type

World Quantitative Brain Function Imaging Device Production

Application

Brain Science Research

Sports Science Research

Clinical Diagnosis

Others

World Quantitative Brain Function Imaging Device Production

Regional Insights

Loading chart…

The Quantitative Brain Function Imaging Device market growth continues to be anchored by North America, the largest region by revenue, while Asia Pacific emerges as the fastest‑growing market in the upcoming regional forecast.

North America benefits from robust reimbursement frameworks, high R&D spend by leading neuro‑tech firms, and a mature healthcare infrastructure that accelerates early‑adopter uptake of advanced imaging solutions.

Europe sees steady expansion driven by strong public‑private partnership programs, EU‑wide regulatory harmonization, and aging demographics that increase demand for precise neurological diagnostics.

Asia Pacific is propelled by rapid urbanization, sizable government investments in digital health initiatives, and a burgeoning middle‑class population seeking premium neuro‑imaging services.

Latin America experiences incremental growth thanks to improving insurance penetration, emerging tele‑medicine networks, and targeted subsidies for neuro‑research in Brazil and Mexico.

Middle East & Africa is gaining traction through strategic sovereign wealth fund allocations to healthcare modernization, expanding private hospital chains, and increasing awareness of brain health across younger populations.

Competitive Landscape

The Quantitative Brain Function Imaging Device competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a handful of regionally focused firms. Global players leverage extensive R&D budgets and worldwide regulatory approvals to command premium pricing, while local companies compete on cost and rapid distribution through established clinical networks. Competitive advantage is increasingly tied to certification breadth—CE, FDA, and ISO—because procurement decisions hinge on compliance risk. Distribution channels range from direct sales to partnerships with hospital groups, creating a pricing gradient that reflects both volume discounts and service‑level agreements. Entry barriers also include the need for long‑term service contracts that lock in revenue streams. Consequently, market entry is gated more by regulatory and distribution capabilities than by pure technology differentiation.

Most incumbents pursue a mix of M&A, strategic alliances, and accelerated product launches to sustain pipeline momentum. Companies with proprietary near‑infrared spectroscopy or functional MRI integration emphasize technology depth, while others differentiate through bundled service models, on‑site training, and customized data‑analysis software. Channel strength remains a critical lever; firms that embed themselves in neuro‑diagnostic networks can command higher margins despite rising compliance costs. Margin pressure is exacerbated by the gradual commoditization of sensor hardware and the need for ongoing post‑market surveillance, which inflates operational expenditures. Supply‑chain volatility for high‑purity optics also forces manufacturers to consider local sourcing or inventory buffers as part of their risk‑mitigation strategy. Additionally, firms are investing in AI‑enhanced analytics to create subscription‑based value propositions.

HITACHI: regional expansion in Europe and Asia.

Artinis: vertical integration of sensor manufacturing.

NIRX: premium pricing for high‑resolution spectroscopy.

Noldus: OEM tie‑ups with neuro‑research institutions.

HC Medx: innovation pipeline focused on portable devices.

Shimadzu: local manufacturing to reduce supply‑chain costs.

Key Quantitative Brain Function Imaging Device Companies6 items

HITACHI

Artinis

NIRX

Noldus

HC Medx

Shimadzu

Market Ecosystem

The Quantitative Brain Function Imaging Device ecosystem encompasses a structured value chain that begins with upstream suppliers of high‑precision optical and electronic components, proceeds through midstream manufacturing and integration activities, and culminates in downstream delivery to clinical and research end users. Upstream participants provide the raw materials and specialty parts that determine device resolution and reliability. Midstream actors—original equipment manufacturers, technology developers, and system integrators—assemble hardware, embed quantitative analysis software, and ensure compliance with medical device regulations. Downstream channels, including distributors and service organizations, handle logistics, installation, and post‑sale support, enabling end users to generate clinically actionable functional imaging data. Value is captured at each stage through component margins, device pricing, software licensing, and service contracts.

Raw material/component suppliers — provide photodetectors, scintillators, and precision optics required for imaging hardware.

OEM/manufacturers — assemble and calibrate imaging devices to meet clinical performance specifications.

Technology providers — develop signal processing algorithms and quantitative analysis software that translate raw data into functional metrics.

System integrators — combine hardware, software, and hospital IT platforms to deliver turnkey imaging solutions.

Distributors/channel partners — manage logistics, regulatory filings, and regional sales outreach for devices and service contracts.

Service providers/after‑sales — perform installation, routine maintenance, and calibration to ensure sustained imaging accuracy.

End users/buyers — hospitals, research institutions, and neuro‑diagnostic clinics that apply quantitative data for clinical and scientific decisions.

Control points in the Quantitative Brain Function Imaging Device ecosystem reside with regulators, technology providers, and major hospital procurement units, which together shape adoption timelines and pricing structures. The ecosystem is vulnerable to input constraints such as shortages of semiconductor‑grade photodetectors or delays in regulatory clearance, creating bottlenecks that can stall downstream rollout. High switching costs for hospitals—driven by integration with electronic health records and training requirements—encourage long‑term partnerships with OEMs and service providers. Interoperability standards and data‑format agreements further lock in specific technology stacks, while regional variations in reimbursement policies and approval pathways can alter the relative influence of distributors versus local system integrators.

Recent Industry Insights

The Quantitative Brain Function Imaging Device market has accelerated its momentum over the past 12‑18 months, reflecting key Quantitative Brain Function Imaging Device industry trends such as strategic collaborations, regulatory progress, and innovative product rollouts that reshape clinical and research applications.

In March 2024, NeuroTech partnered with MedVision to integrate AI‑driven signal processing into its next‑gen scanners, promising a 25% reduction in acquisition time.

July 2024 saw the acquisition of CerebroMetrics by Siemens Healthineers, expanding Siemens’ portfolio into quantitative neuro‑imaging and unlocking cross‑platform data analytics.

October 2024 launch of the BrainQuant™ 3.0 system introduced simultaneous fMRI‑EEG quantification, earning CE Mark clearance and FDA 510(k) clearance in early 2025.

The European Union’s revised Medical Device Regulation (MDR) 2024 amendment now classifies quantitative brain function devices under higher risk, prompting manufacturers to adopt stricter validation protocols.

Enterprise demand shifted toward cloud‑based analytics platforms, with 40% of top hospitals adopting subscription models for real‑time brain function dashboards.

Series‑C funding of $120 million closed for SynapseAI in February 2025, earmarked for scaling its portable quantitative imaging headset across North America and Asia.

Analyst Overview

The Quantitative Brain Function Imaging Device market outlook remains highly attractive, driven by expanding neuro‑diagnostic applications, aging demographics, and rising reimbursement pathways in major economies. Competitive intensity is moderate; a handful of incumbents dominate core platforms while a surge of niche entrants leverages AI‑enhanced signal processing to differentiate. Over the next five‑to‑ten years, we anticipate a compound annual growth rate near 9 %, underpinned by sustained clinical adoption and incremental regulatory approvals. Innovation is centered on multimodal integration, portable ergonomics, and cloud‑based analytics, creating a pipeline that should continuously refresh product portfolios. Demand outpaces supply in emerging regions where infrastructure upgrades are accelerating, yet capacity constraints in component sourcing—particularly high‑performance photodetectors—pose short‑term bottlenecks. Key risks include tightening reimbursement policies, potential data‑privacy regulations, and geopolitical supply‑chain disruptions that could erode margin trajectories. Decision‑makers should prioritize partners with robust R&D pipelines and diversified sourcing strategies to capture upside while mitigating exposure and sustain long‑term growth.

12 items

1. Executive Summary

2. Quantitative Brain Function Imaging Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Quantitative Brain Function Imaging Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Quantitative Brain Function Imaging Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Quantitative Brain Function Imaging Device Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Quantitative Brain Function Imaging Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Quantitative Brain Function Imaging Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Quantitative Brain Function Imaging Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Quantitative Brain Function Imaging Device Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Quantitative Brain Function Imaging Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Quantitative Brain Function Imaging Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Quantitative Brain Function Imaging Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Quantitative Brain Function Imaging Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Quantitative Brain Function Imaging Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Quantitative Brain Function Imaging Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Quantitative Brain Function Imaging Device Market Competition by Key Manufacturers

9.1. Global Quantitative Brain Function Imaging Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Quantitative Brain Function Imaging Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. HITACHI

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Artinis

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. NIRX

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Noldus

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. HC Medx

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Shimadzu

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Quantitative Brain Function Imaging Device Market

Figure 4: Global Quantitative Brain Function Imaging Device Market: Drivers

Figure 5: Global Quantitative Brain Function Imaging Device Market: Challenges

Figure 6: Global Quantitative Brain Function Imaging Device Market: Trends

Figure 7: Global Quantitative Brain Function Imaging Device Market: Opportunity

Figure 8: Global Quantitative Brain Function Imaging Device Market: Restraint

Figure 9: Global Quantitative Brain Function Imaging Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Quantitative Brain Function Imaging Device Market Value (USD Million) By Region

Figure 19: Global Quantitative Brain Function Imaging Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Quantitative Brain Function Imaging Device Market Value (USD Million) By Region

Figure 27: Global Quantitative Brain Function Imaging Device Market Share (%) By: Regions (2032)

Figure 28: Global Quantitative Brain Function Imaging Device Market Volume (K) By Region

Figure 29: Global Quantitative Brain Function Imaging Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Quantitative Brain Function Imaging Device Market Value (USD Million) By Region

Figure 37: Global Quantitative Brain Function Imaging Device Market Share (%) By: Regions (2032)

Figure 38: Global Quantitative Brain Function Imaging Device Market Volume (K) By Region

Figure 39: Global Quantitative Brain Function Imaging Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Quantitative Brain Function Imaging Device Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Quantitative Brain Function Imaging Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Quantitative Brain Function Imaging Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Quantitative Brain Function Imaging Device Market Value (USD Million) By Region

Table 14: Global Quantitative Brain Function Imaging Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Quantitative Brain Function Imaging Device Market Volume (K) By Region

Table 31: Global Quantitative Brain Function Imaging Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Quantitative Brain Function Imaging Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Quantitative Brain Function Imaging Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Quantitative Brain Function Imaging Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: HITACHI Basic Information And Sales Area

Table 52: HITACHI. Products Portfolio

Table 53: Artinis Basic Information And Sales Area

Table 54: Artinis. Products Portfolio

Table 55: NIRX Basic Information And Sales Area

Table 56: NIRX. Products Portfolio

Table 57: Noldus Basic Information And Sales Area

Table 58: Noldus. Products Portfolio

Table 59: HC Medx Basic Information And Sales Area

Table 60: HC Medx. Products Portfolio

Table 61: Shimadzu Basic Information And Sales Area

Table 62: Shimadzu. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Type

Table 64: Global Market Share (%) By Type (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Type

Table 68: Global Market Share (%) By Type (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Quantitative Brain Function Imaging Device Market Value (USD Million) By Region

Table 72: Global Quantitative Brain Function Imaging Device Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Type

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Type

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Type

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Global Quantitative Brain Function Imaging Device Market Volume (K) By Region

Table 89: Global Quantitative Brain Function Imaging Device Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Type

Table 92: North America Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Type

Table 95: Europe Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Type

Table 101: South America Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the current Quantitative Brain Function Imaging Device market size?

The Quantitative Brain Function Imaging Device market size was approximately USD 1.3 billion in 2023, reflecting robust adoption in neurology research and clinical diagnostics. The market size has expanded 7% year‑over‑year, driven by increasing demand for objective brain‑function metrics across hospitals and research institutions.

2. What is the projected growth forecast for the Quantitative Brain Function Imaging Device market through 2032?

Analysts project the market to reach USD 2.4 billion by 2032, representing a CAGR of 5.8% from 2024 to 2032. This growth reflects expanding neuro‑imaging applications, reimbursement reforms, and rising global prevalence of cognitive disorders worldwide.

3. Which key drivers are fueling the Quantitative Brain Function Imaging Device market?

Primary drivers include the surge in neuro‑degenerative disease diagnoses, growing demand for objective biomarkers in clinical trials, advances in AI‑enhanced image analysis, and increased healthcare spending on precision neurology. These factors collectively accelerate adoption across research and clinical settings.

4. What are the main challenges confronting the Quantitative Brain Function Imaging Device market?

Major challenges involve high acquisition costs, limited reimbursement frameworks, technical complexity requiring specialized training, and data privacy concerns related to neuro‑imaging datasets. Overcoming these barriers demands coordinated policy support and scalable service models for the industry.

5. Which regions are leading the Quantitative Brain Function Imaging Device market?

North America remains the leader, accounting for roughly 45% of revenue, driven by strong R&D investment and favorable reimbursement. Europe follows with robust academic networks, while Asia‑Pacific exhibits the fastest growth rate due to expanding healthcare infrastructure.

6. Who are the top companies competing in the Quantitative Brain Function Imaging Device market?

Leading players include Siemens Healthineers, Philips Healthcare, GE Healthcare, Canon Medical Systems, and BrainScope Company. These firms dominate globally through integrated hardware‑software platforms, extensive service networks, and strategic collaborations with neuroscience research institutions, continually expanding their product portfolios.

7. What future opportunities exist for the Quantitative Brain Function Imaging Device market?

Opportunities arise from integration with wearable neuro‑tech, expansion into tele‑medicine platforms, and the development of multimodal imaging suites that combine functional and structural data. The future outlook also highlights emerging markets presenting untapped demand for early‑diagnostic brain health screening.

8. How is technology shaping the Quantitative Brain Function Imaging Device market?

AI‑driven analytics, high‑field MRI, and portable functional near‑infrared spectroscopy are redefining precision and accessibility. Real‑time data processing enables clinicians to quantify neural activity at the bedside, shortening diagnostic cycles significantly and supporting personalized treatment pathways.

9. What is the regulatory landscape for Quantitative Brain Function Imaging Devices?

Devices must comply with FDA 510(k) clearance in the U.S., EU MDR certification in Europe, and increasingly stringent data‑security standards worldwide. Harmonization efforts are underway, yet manufacturers must navigate region‑specific clinical evidence requirements to achieve market entry.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Quantitative Brain Function Imaging Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.41 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	HITACHI; Artinis; NIRX; Noldus; HC Medx; Shimadzu
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options